FRAXIPARINA

This brand name is authorized in Germany, Lithuania, Spain.

Active ingredients

The drug FRAXIPARINA contains one active pharmaceutical ingredient (API):

1	Nadroparin UNII LIA7Z4002P - NADROPARIN CALCIUM
	Nadroparin is a low-molecular weight heparin. Nadroparin inhibits Factor Xa in particular and thrombin to a lesser extent. Inhibition is partially mediated via the plasma protease inhibitor antithrombin III. Nadroparin has less effect on platelet function and aggregation and only has a minor effect on primary haemostasis compared to heparin.
	Read more about Nadroparin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AB06	Nadroparin	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AB Heparin group
Discover more medicines within B01AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00842549, 00842555, 00842584, 00842590, 00842609, 00842615, 00842621, 00842704, 00885754, 00885777, 00885814, 00885820, 00885843, 00929345, 00929351, 01752676, 01975502, 01975519, 01975525, 01975548, 01975577, 01975608, 01975620, 01975637, 02179983, 02561659, 02561665, 02561671, 02561688, 06793964, 07448703, 07448726, 10418539
ES	Centro de información online de medicamentos de la AEMPS	63496, 63497
LT	Valstybinė vaistų kontrolės tarnyba	1092840, 1092841